References
Morrison S, Han G, Elenwa F, Vetto J, Fowler G, Leong SP, et al. Is the presence of tumor infiltrating lymphocytes prognostic in melanoma patients? Cancer. 2021.
Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77(7):1303–10.
Letca AF, Ungureanu L, Senila SC, et al. Regression and sentinel lymph node status in melanoma progression. Med Sci Monit. 2018;24:1359–65.
Morrison S, Han G, Elenwa F, Vetto J, Fowler G, Leong SP, et al. Is there a relationship between TIL and regression in melanoma? Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11251-z.
Aung PP, Nagarajan P, Prieto VG. Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance. Lab Invest. 2017;97(6):657–68.
Funding
This work was not supported by any funding source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
JSZ research funding from Amgen, Castle Biosciences, Delcath Systems, Novartis, Provectus and Philogen; medical advisory board for Delcath Systems, speakers’ bureau for Sun Pharma, Pfizer, and consultant for Merck, Sanofi/Regeneron, Amgen, Castle Biosciences. JTV speaker for Castle Biosciences.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morrison, S., Zager, J.S. & Vetto, J. ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?. Ann Surg Oncol 29, 2867–2868 (2022). https://doi.org/10.1245/s10434-021-11264-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11264-8